Eyal Flom

Director/Board Member at INNOCAN PHARMA CORPORATION

Net worth: 534 437 $ as of 2024-03-30

59 year

16 connections

Health Technology

Consumer Services

Distribution Services

Profile

Eyal Flom is currently the Director at Revium Recovery, Inc. He is also the Secretary & Director at InnoCan Pharma Corp.
and the Director at NurExone Biologic Ltd.
In the past, he served as the Legal Counsel at the Israeli Pharmaceutical Association.
Mr. Flom's former job includes being the Director at NurExone Biologic, Inc. Mr. Flom holds an MBA from the University of Derby and a graduate degree from Tel-Aviv University.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
INNOCAN PHARMA CORPORATION 0.89%	2024-03-24	2,375,277 ( 0.89% )	534 437 $	2024-03-30

Eyal Flom active positions

Companies	Position	Start
INNOCAN PHARMA CORPORATION	Director/Board Member	2019-09-24
REVIUM RECOVERY INC.	Director/Board Member	-
Israeli Pharmaceutical Association	General Counsel	1995-03-31
NurExone Biologic Ltd. NurExone Biologic Ltd. Pharmaceuticals: MajorHealth Technology Part of NurExone Biologic, Inc., NurExone Biologic Ltd. is an Israeli company that offers a new approach to Spinal Cord Injury treatment. The private company is based in Bnei-Brak, Israel. The company believes that intranasal exosome administration offers an alternative to cell transplantation. The company was founded in 2020 by Yoram Nathan Drucker. Lior Shaltiel has been the CEO of the company since 2021. NurExone Biologic was acquired by EnerSpar Corp. on June 15, 2022.	Director/Board Member	-

All active positions of Eyal Flom

Former positions of Eyal Flom

Companies	Position	End
NUREXONE BIOLOGIC INC.	Director/Board Member	2023-05-07

See the detail of Eyal Flom's experience

Training of Eyal Flom

University of Derby	Masters Business Admin
Tel-Aviv University	Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Eyal Flom's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	3
REVIUM RECOVERY INC.	Distribution Services
INNOCAN PHARMA CORPORATION	Health Technology
NUREXONE BIOLOGIC INC.	Health Technology

Private companies	2
Israeli Pharmaceutical Association
NurExone Biologic Ltd. NurExone Biologic Ltd. Pharmaceuticals: MajorHealth Technology Part of NurExone Biologic, Inc., NurExone Biologic Ltd. is an Israeli company that offers a new approach to Spinal Cord Injury treatment. The private company is based in Bnei-Brak, Israel. The company believes that intranasal exosome administration offers an alternative to cell transplantation. The company was founded in 2020 by Yoram Nathan Drucker. Lior Shaltiel has been the CEO of the company since 2021. NurExone Biologic was acquired by EnerSpar Corp. on June 15, 2022.	Health Technology